Nordic Nanovector
NANOV today provides an update on PARADIGME its Phase 2b trial of Betalutin 177Lu lilotomab satetraxetan in 3rd-line relapsed and…
Wednesday, July 6, 2022
Edit
Showing posts with label Nordic. Show all posts
Showing posts with label Nordic. Show all posts
Subscribe to:
Posts (Atom)